文章摘要
孙楠1 张林1 刘永煜2 郑世营3 赵翔2.痰液脱落细胞中p16 基因和RASSF1A 基因甲基化与周边型非小细胞 肺癌关系的研究[J].,2012,12(13):2503-2510
痰液脱落细胞中p16 基因和RASSF1A 基因甲基化与周边型非小细胞 肺癌关系的研究
Methylation of P16 and RASSF1A Genes in Sputum Samples Associatedwith Peripheral Non-Small Cell Lung Cancer
  
DOI:
中文关键词: p16  RASSF1A  甲基化  非小细胞肺癌  MSP
英文关键词: p16  RASSF1A  Methylation  Non--small cell lung cancer  MSP
基金项目:辽宁省自然科学基金项目(20102120)
作者单位
孙楠1 张林1 刘永煜2 郑世营3 赵翔2 中国医科大学附属第一医院胸外科 
摘要点击次数: 858
全文下载次数: 0
中文摘要:
      目的:探讨p16 基因和RASSF1A 基因甲基化与肺癌发生发展的关系和应用于诊断的意义。方法:采用甲基化特异性PCR (Methylation Specific PCR,MSP)检测120 例周边型非小细胞肺癌患者癌组织、痰液脱落细胞和120 例非肺癌人群的痰液脱落细 胞中p16 基因和RASSF1A 基因甲基化,分析它们与临床特征的关系以及非肺癌人群与肿瘤患者之间的差异。结果:(1)120 例周 边型非小细胞肺癌组织中,p16 基因甲基化率46.7%(56 例),RASSF1A 基因甲基化率53.3%(64 例)。P16 和RASSF1A 基因甲基 化与吸烟程度、肿瘤大小和临床分期正相关(P<0.05)。(2)肺癌痰液脱落细胞中有28 例p16 基因出现甲基化(23.3%),20 例 RASSF1A 基因出现甲基化(16.7%),其中32 例至少存在一个基因的甲基化(26.7%);66 例重度吸烟者中只有4 例痰液脱落细胞 出现p16 基因甲基化(6%),4 例出现RASSF1A 基因甲基化(6%);54 例非重度吸烟正常人中仅有2 例出现p16 基因甲基化 (3.7%),RASSF1A 基因无甲基化。(3)液基痰细胞病理学检查与痰脱落细胞p16 和RASSF1a 基因甲基化检测结合起来可有效提 高诊断的灵敏度(P<0.05)。结论:烟草可能具有潜在的诱导抑癌基因p16 和RASSF1A 发生甲基化的作用;p16 和RASSF1A 基 因甲基化可能参与肺癌的生长过程。痰脱落细胞p16 和RASSF1a 基因甲基化检测结合液基痰细胞病理学诊断,可提高非小细胞 肺癌诊断的灵敏度。
英文摘要:
      Objective: To investigate the relativity between p16 and RASSF1A gene methylation and development of peripheral non-small cell lung cancer, and investigate the value of detection of p16 and RASSF1A gene methylation in sputum cells as diagnosis method of non-small cell lung cancer. Methods: Methylation-specific PCR(MSP)was performed to detect the methylation status of p16 and RASSF1A genes in tissue and sputum cells of 120 cases of peripheral non-small cell lung cancer, and in sputum cells of 120 cases of cancer-free. The relationship between the methylation status and the clinic factors was analyzed. Results: (1) The frequencies of methylation of the p16 and RASSF1a genes in tissue of peripheral non-small cell lung cancer were: 46.7% (56 of 120) and 53.3% (64 of 120). There was a significant higher ratio of p16 and RASSF1A gene methylation in the degree of smoking, size of tumor and advanced clinical stage (P<0.05). (2) The frequencies of methylation of the genes in sputum of non-small cell lung cancer, heavy-smoking and normal samples were: 23.3% (28 of 120) , 6% (4 of 66) and 3.7% (2 of 54) for p16, and 16.7% (20 of 120), 6% (4 of 66) and 0 (0 of 54) for RASSF1A, respectively. (3) Combination of Liquid-based cytological analysis and detection of p16 and RASSF1a genes methylation in sputum could increase the sensitivity of diagnostic approach for non-small cell lung cancer (P<0.05). Conclusion: These results indicate that the tobacco may have the potential capability to induce methylation of p16 and RASSF1A genes. In addition, the Methylation of p16 and RASSF1A maybe play important roles in growth process of non-small cell lung cancer. Combination of Liquid-based cytological analysis and detection of p16 and RASSF1a genes methylation in sputum could be a more sensitive method for the diagnosis of this malignancy.
查看全文   查看/发表评论  下载PDF阅读器
关闭